QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 25 January 2005
doi: 10.1242/jcs.01657

This Article Figures Only Full Text Full Text (PDF) Supplementary Material All Versions of this Article: jcs.01657v1 118/4/795    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ma, R. Y. M. Articles by Yao, K.-M. Search for Related Content PubMed PubMed Citation Articles by Ma, R. Y. M. Articles by Yao, K.-M. Social Bookmarking                         What's this?

Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c

Department of Biochemistry, Faculty of Medicine, The University of Hong Kong, 3/F Laboratory Block, The Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong, China

^* Author for correspondence (e-mail: kmyao{at}hkusua.hku.hk)

Accepted 22 November 2004

The forkhead box (FOX) transcription factor FOXM1 is ubiquitously expressed in proliferating cells. FOXM1 expression peaks at the G2/M phase of the cell cycle and its functional deficiency in mice leads to defects in mitosis. To investigate the role of FOXM1 in the cell cycle, we used synchronized hTERT-BJ1 fibroblasts to examine the cell cycle-dependent regulation of FOXM1 function. We observed that FOXM1 is localized mainly in the cytoplasm in cells at late-G1 and S phases. Nuclear translocation occurs just before entry into the G2/M phase and is associated with phosphorylation of FOXM1. Consistent with the dependency of FOXM1 function on mitogenic signals, nuclear translocation of FOXM1 requires activity of the Raf/MEK/MAPK signaling pathway and is enhanced by the MAPK activator aurintricarboxylic acid. This activating effect was suppressed by the MEK1/2 inhibitor U0126. In transient reporter assays, constitutively active MEK1 enhances the transactivating effect of FOXM1c, but not FOXM1b, on the cyclin B1 promoter. RT-PCR analysis confirmed that different cell lines and tissues predominantly express the FOXM1c transcript. Mutations of two ERK1/2 target sequences within FOXM1c completely abolish the MEK1 enhancing effect, suggesting a direct link between Raf/MEK/MAPK signaling and FOXM1 function. Importantly, inhibition of Raf/MEK/MAPK signaling by U0126 led to suppression of FOXM1 target gene expression and delayed progression through G2/M, verifying the functional relevance of FOXM1 activation by MEK1. In summary, we provide the first evidence that Raf/MEK/MAPK signaling exerts its G2/M regulatory effect via FOXM1c.

Key words: FOXM1c, Raf/MEK/MAPK, Nucleocytoplasmic shuttling, Cyclin B1, G2/M

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				U. B. McGovern, R. E. Francis, B. Peck, S. K. Guest, J. Wang, S. S. Myatt, J. Krol, J. M-M. Kwok, A. Polychronis, R. C. Coombes, et al. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer Mol. Cancer Ther., March 1, 2009; 8(3): 582 - 591. [Abstract] [Full Text] [PDF]

				J. M-M. Kwok, S. S. Myatt, C. M. Marson, R. C. Coombes, D. Constantinidou, and E. W-F. Lam Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression Mol. Cancer Ther., July 1, 2008; 7(7): 2022 - 2032. [Abstract] [Full Text] [PDF]

				S. K. M. Li, D. K. Smith, W. Y. Leung, A. M. S. Cheung, E. W. F. Lam, G. P. Dimri, and K.-M. Yao FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression J. Biol. Chem., June 13, 2008; 283(24): 16545 - 16553. [Abstract] [Full Text] [PDF]

				J. Laoukili, M. Alvarez, L. A. T. Meijer, M. Stahl, S. Mohammed, L. Kleij, A. J. R. Heck, and R. H. Medema Activation of FoxM1 during G2 Requires Cyclin A/Cdk-Dependent Relief of Autorepression by the FoxM1 N-Terminal Domain Mol. Cell. Biol., May 1, 2008; 28(9): 3076 - 3087. [Abstract] [Full Text] [PDF]

				A. Djamei, A. Pitzschke, H. Nakagami, I. Rajh, and H. Hirt Trojan Horse Strategy in Agrobacterium Transformation: Abusing MAPK Defense Signaling Science, October 19, 2007; 318(5849): 453 - 456. [Abstract] [Full Text] [PDF]

				M. Shinohara, A. V. Mikhailov, J. A. Aguirre-Ghiso, and C. L. Rieder Extracellular Signal-regulated Kinase 1/2 Activity Is Not Required in Mammalian Cells during Late G2 for Timely Entry into or Exit from Mitosis Mol. Biol. Cell, December 1, 2006; 17(12): 5227 - 5240. [Abstract] [Full Text] [PDF]

				P. A. Madureira, R. Varshochi, D. Constantinidou, R. E. Francis, R. C. Coombes, K.-M. Yao, and E. W.-F. Lam The Forkhead Box M1 Protein Regulates the Transcription of the Estrogen Receptor {alpha} in Breast Cancer Cells J. Biol. Chem., September 1, 2006; 281(35): 25167 - 25176. [Abstract] [Full Text] [PDF]

				I.-M. Kim, T. Ackerson, S. Ramakrishna, M. Tretiakova, I-C. Wang, T. V. Kalin, M. L. Major, G. A. Gusarova, H. M. Yoder, R. H. Costa, et al. The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer Cancer Res., February 15, 2006; 66(4): 2153 - 2161. [Abstract] [Full Text] [PDF]